US$ 29.77
pentadecapeptide arginate bpc 157 and the... : European Journal of Pharmacology BPC-157 Pentadecapeptide Arginate 500mcg (PDA)
Description
SOCS7, suppressor of cytokine signaling 7

Such findings led scientists to label AOD-9604 as the worlds first drug with a metabolic mechanism of action for obesity meaning it works by accelerating fat metabolism rather than suppressing appetite

The compounds described are strictly intended for laboratory research and in-vitro studies only

Mongardi Fantaguzzi C, Thacker M, Chiocchetti R, Furness JB

Quick Answer: AOD-9604 is administered via subcutaneous injection into the fatty tissue beneath the skin

Current Medicinal Chemistry